Evidence map›Paper›PMID 25261933›Full record

ArticleNature genetics2014

Reappraisal of known malaria resistance loci in a large multicenter study.

Malaria Genomic Epidemiology Network, Malaria Genomic Epidemiology Network

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Nature genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 141 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
141citing papers in PubMed, 2 pooled it
26.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

141 citing papers in PubMed, 2 syntheses or guidelines pooled it, 240 citations in OpenAlex.

  1. Artemisinin Therapy for Malaria in Hemoglobinopathies: A Systematic Review.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. The CYB5R3American journal of hematology · 2020
    Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. No G6PD A- (G202A) variant detected amongMalariaWorld journal · 2026
    Article
  13. Article
  14. Article
  15. Human genetic variations conferring resistance to malaria.Journal of translational medicine · 2025
    Review
  16. Mendelian Randomization and Infection: Pitfalls and Promises.The Journal of infectious diseases · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. The intersection of hostMicrobiology and molecular biology reviews : MMBR · 2024
    Review

81 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 20 institutions in 16 countries.

Malaria Genomic Epidemiology Network
Malaria Genomic Epidemiology Network
Centre for Human Genetics · GBUniversity of Bamako · MLThe University of Western Australia · AUUniversity of Buea · CMKenya Medical Research Institute · KENuffield Orthopaedic Centre · GBMRC Unit the Gambia · GMCentre National de Recherche et de Formation sur le Paludisme · BFLondon School of Hygiene & Tropical Medicine · GBNoguchi Memorial Institute for Medical Research · GHOxford University Clinical Research Unit · VNKomfo Anokye Teaching Hospital · GHUniversity of Ibadan · NGUniversity of Liverpool · GBDivine Word University · PGEdward Francis Small Teaching Hospital · GMKwame Nkrumah University of Science and Technology · GHNavrongo Health Research Centre · GHPapua New Guinea Institute of Medical Research · PGSwansea University · GB

Funding

MALARIA RESEARCH TRAINING IN MALID43TW001589 · FIC · UNIVERSITY OF MARYLAND BALTIMORE · PI PLOWE, CHRISTOPHER V. · 2000 to 2015
$2.8M
FIC NIH HHS D43 TW001589Medical Research Council G0600230Medical Research Council G0600718Medical Research Council G19/9Medical Research Council G9901439Medical Research Council MC_UP_A900_1118Wellcome Trust 076934/Z/05/ZWellcome Trust 084538Wellcome Trust 087285Wellcome Trust 089276/Z/09/ZWellcome Trust 090532Wellcome Trust 090532/Z/09/ZWellcome Trust 090770Wellcome Trust 090770/Z/09/ZWellcome Trust 091758Wellcome Trust 091758/Z/10/ZWellcome Trust 096527Wellcome Trust 097364/Z/11/ZWellcome Trust 098051/Z/05/ZWellcome Trust WT077383/Z/05/Z
6 · The paper itself

Abstract

Many human genetic associations with resistance to malaria have been reported, but few have been reliably replicated. We collected data on 11,890 cases of severe malaria due to Plasmodium falciparum and 17,441 controls from 12 locations in Africa, Asia and Oceania. We tested 55 SNPs in 27 loci previously reported to associate with severe malaria. There was evidence of association at P < 1 × 10(-4) with the HBB, ABO, ATP2B4, G6PD and CD40LG loci, but previously reported associations at 22 other loci did not replicate in the multicenter analysis. The large sample size made it possible to identify authentic genetic effects that are heterogeneous across populations or phenotypes, with a striking example being the main African form of G6PD deficiency, which reduced the risk of cerebral malaria but increased the risk of severe malarial anemia. The finding that G6PD deficiency has opposing effects on different fatal complications of P. falciparum infection indicates that the evolutionary origins of this common human genetic disorder are more complex than previously supposed.

Indexed as

Africa South of the SaharaCase-Control StudiesDisease ResistanceGenetic Association StudiesGenetic LociGlucosephosphate DehydrogenaseGlucosephosphate Dehydrogenase DeficiencyHumansLogistic ModelsMalaria, FalciparumPapua New GuineaPlasma Membrane Calcium-Transporting ATPasesPolymorphism, Single NucleotideVietnamATP2B4 protein, humanGlucosephosphate DehydrogenasePlasma Membrane Calcium-Transporting ATPases

Identifiers

PMID25261933
PMCPMC4617542
OpenAlexW2136369890

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.